Your browser is no longer supported. Please, upgrade your browser.
Settings
IRIX IRIDEX Corporation daily Stock Chart
IRIX [NASD]
IRIDEX Corporation
Index- P/E222.92 EPS (ttm)0.07 Insider Own2.70% Shs Outstand10.12M Perf Week-1.63%
Market Cap146.64M Forward P/E49.97 EPS next Y0.29 Insider Trans-8.98% Shs Float9.45M Perf Month-2.95%
Income0.70M PEG7.43 EPS next Q-0.03 Inst Own63.40% Short Float3.32% Perf Quarter-6.58%
Sales45.80M P/S3.20 EPS this Y-95.20% Inst Trans12.88% Short Ratio10.95 Perf Half Y41.09%
Book/sh3.42 P/B4.24 EPS next Y1066.70% ROA1.50% Target Price16.00 Perf Year88.43%
Cash/sh1.14 P/C12.75 EPS next 5Y30.00% ROE1.90% 52W Range7.18 - 16.64 Perf YTD55.97%
Dividend- P/FCF733.19 EPS past 5Y-22.00% ROI1.40% 52W High-12.92% Beta0.70
Dividend %- Quick Ratio2.40 Sales past 5Y5.30% Gross Margin46.70% 52W Low101.81% ATR0.50
Employees108 Current Ratio3.80 Sales Q/Q32.20% Oper. Margin0.70% RSI (14)41.81 Volatility2.87% 3.14%
OptionableNo Debt/Eq0.00 EPS Q/Q50.00% Profit Margin1.40% Rel Volume0.54 Prev Close14.28
ShortableYes LT Debt/Eq0.00 EarningsNov 03 AMC Payout0.00% Avg Volume28.61K Price14.49
Recom1.00 SMA20-3.49% SMA50-3.63% SMA20017.89% Volume15,415 Change1.47%
Jan-26-16Initiated Singular Research Buy $11.50
Jan-03-07Initiated First Albany Buy $15.50
Sep-07-16 06:30AM  IRIDEX Announces Long-Term Glaucoma Efficacy Data for Patients Treated with MicroPulse® P3 Probe Technology PR Newswire
Aug-24-16 12:03PM  ETFs with exposure to IRIDEX Corp. : August 24, 2016
Aug-17-16 01:04PM  IRIDEX CORP Financials
Aug-15-16 05:59PM  Edited Transcript of IRIX earnings conference call or presentation 4-Aug-16 9:00pm GMT
01:52PM  IRIDEX Corp. :IRIX-US: Earnings Analysis: Q2, 2016 By the Numbers : August 15, 2016
Aug-08-16 05:03PM  IRIDEX CORP Files SEC form 10-Q, Quarterly Report
Aug-04-16 06:35PM  Iridex reports 2Q loss
05:00PM  IRIDEX Corp Earnings Call scheduled for 5:00 pm ET today
04:33PM  IRIDEX CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
04:05PM  IRIDEX Reports 2016 Second Quarter, Six-Month Results PR Newswire
07:07AM  Q2 2016 IRIDEX Corp Earnings Release - After Market Close
Jul-28-16 04:05PM  IRIDEX Announces Second Quarter 2016 Conference Call and Release Date PR Newswire
Jul-21-16 02:09PM  ETFs with exposure to IRIDEX Corp. : July 21, 2016
Jul-11-16 04:17PM  IRIDEX CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Termination of a Material Definitive Agre
06:30AM  IRIDEX Announces Atabak Mokari Will Be Chief Financial Officer And VP Corporate Development PR Newswire
Jun-21-16 04:17PM  IRIDEX CORP Files SEC form 8-K, Submission of Matters to a Vote of Security Holders
Jun-09-16 04:33PM  IRIDEX CORP Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
Jun-02-16 04:05PM  IRIDEX to Present at the Singular Research 11th Annual Best of the Uncovereds Spring Select Conference PR Newswire
May-11-16 11:57AM  IRIDEX Corp. :IRIX-US: Earnings Analysis: Q1, 2016 By the Numbers
May-10-16 07:00AM  IRIDEX Announces Cyclo G6 with MicroPulse® P3 Clinical Data Presented at ARVO and ASCRS Annual Meetings PR Newswire
May-09-16 06:08PM  IRIDEX CORP Files SEC form 10-Q, Quarterly Report
May-05-16 06:24PM  Iridex posts 1Q profit
05:00PM  IRIDEX Corp Earnings Call scheduled for 5:00 pm ET today
04:59PM  IRIDEX CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
04:05PM  IRIDEX Reports 2016 First Quarter Results PR Newswire
07:07AM  Q1 2016 IRIDEX Corp Earnings Release - After Market Close CCBN
Apr-28-16 04:05PM  IRIDEX Announces First Quarter 2016 Conference Call and Release Date PR Newswire
Mar-31-16 05:20PM  IRIDEX CORP Files SEC form 10-K, Annual Report
Mar-22-16 04:31PM  IRIDEX Gains Patent Approvals Covering TxCell-Guided MicroPulse® Laser Therapy; Predictably Enables Faster, Durable Treatments for Glaucoma and Retinal Diseases at noodls
04:05PM  IRIDEX Gains Patent Approvals Covering TxCell-Guided MicroPulse® Laser Therapy; Predictably Enables Faster, Durable Treatments for Glaucoma and Retinal Diseases PR Newswire
Mar-10-16 01:54PM  ETFs with exposure to IRIDEX Corp. : March 10, 2016
Mar-09-16 12:03PM  IRIDEX Corp. :IRIX-US: Earnings Analysis: 2015 By the Numbers
Mar-07-16 05:17PM  IRIDEX CORP Files SEC form 8-K, Change in Directors or Principal Officers
Mar-04-16 02:47PM  Edited Transcript of IRIX earnings conference call or presentation 3-Mar-16 10:00pm GMT
Mar-03-16 05:20PM  Iridex posts 4Q profit
05:03PM  IRIDEX CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
05:00PM  IRIDEX Corp Earnings Call scheduled for 5:00 pm ET today
04:05PM  IRIDEX Reports 2015 Fourth Quarter, Full Year Results PR Newswire
07:07AM  Q4 2015 IRIDEX Corp Earnings Release - After Market Close
Feb-25-16 04:05PM  IRIDEX Announces Fourth Quarter and Full Year 2015 Conference Call and Release Date PR Newswire
Feb-16-16 06:30AM  IRIDEX Receives CE Mark for Cyclo G6 Laser System for the Treatment of Multiple Stages of Glaucoma PR Newswire
Jan-26-16 02:15PM  Coverage initiated on IRIDEX by Singular Research
Jan-12-16 04:04PM  IRIDEX CORP Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
Jan-11-16 04:04PM  IRIDEX CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
06:30AM  IRIDEX Announces Preliminary Unaudited Revenues for 2015 Fourth Quarter and Full Year PR Newswire
Jan-08-16 12:00PM  Edited Transcript of IRIX earnings conference call or presentation 5-Nov-15 10:00pm GMT -5.20%
Dec-21-15 12:24PM  IRIDEX Corp. Earnings Analysis: Q3, 2015 By the Numbers
Dec-02-15 08:30AM  Technical Movement Driving Equities - Research on BIND Therapeutics, Edgewater Technology, IRIDEX, and PRGX Global Accesswire
Dec-01-15 05:29PM  Do Hedge Funds Love IRIDEX Corporation (IRIX)? at Insider Monkey
Nov-26-15 07:45AM  Is Biota Pharmaceuticals Inc (BOTA) A Good Stock To Buy? at Insider Monkey
Nov-11-15 06:30AM  IRIDEX to Showcase Cyclo G6 Laser System Equipped with MicroPulse® Tissue Sparing Glaucoma Technology at American Academy of Ophthalmology (AAO) Meeting PR Newswire
Nov-10-15 05:05PM  IRIDEX CORP Files SEC form 10-Q, Quarterly Report
Nov-05-15 06:48PM  Iridex posts 3Q profit
05:00PM  IRIDEX Corp Earnings Call scheduled for 5:00 pm ET today
04:33PM  IRIDEX CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
04:05PM  IRIDEX Reports 2015 Third Quarter, Nine-Month Results PR Newswire
07:07AM  Q3 2015 IRIDEX Corp Earnings Release - After Market Close
Oct-29-15 04:05PM  IRIDEX Announces Third Quarter 2015 Conference Call and Release Date PR Newswire
Sep-08-15 04:17PM  IRIDEX CORP Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits
06:30AM  IRIDEX Broadens Global Glaucoma Outreach With Novel Eye Pressure Diagnostic Device PR Newswire
Aug-26-15 01:56PM  IRIDEX Corp. Earnings Q2, 2015
Aug-20-15 05:01PM  Edited Transcript of IRIX earnings conference call or presentation 6-Aug-15 9:00pm GMT
Aug-12-15 08:12PM  10-Q for IRIDEX Corp. at Company Spotlight
Aug-10-15 05:44PM  IRIDEX CORP Files SEC form 10-Q, Quarterly Report -7.02%
Aug-06-15 05:00PM  IRIDEX Corp Earnings Call scheduled for 5:00 pm ET today
04:38PM  IRIDEX CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
04:05PM  IRIDEX Reports 2015 Second Quarter, Six-Month Results PR Newswire
10:37AM  Novadaq Technologies, Inc. Earnings Q2*, 2015
07:07AM  Q2 2015 IRIDEX Corp Earnings Release - After Market Close
Aug-04-15 04:32PM  IRIDEX CORP Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits
04:05PM  IRIDEX Chief Financial Officer Resigns to Accept Another Opportunity PR Newswire
Jul-30-15 04:05PM  IRIDEX Announces Second Quarter 2015 Conference Call and Release Date PR Newswire
Jul-16-15 07:02AM  IRIDEX CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits -12.00%
06:30AM  IRIDEX Announces Preliminary Revenues for 2015 Second Quarter PR Newswire
Jun-19-15 04:14PM  IRIDEX CORP Files SEC form 8-K, Submission of Matters to a Vote of Security Holders
Jun-18-15 04:13AM  Edited Transcript of IRIX earnings conference call or presentation 7-May-15 9:00pm GMT
May-28-15 04:01PM  IRIDEX to Present at LD Micro Invitational PR Newswire
May-14-15 08:11PM  10-Q for IRIDEX Corp. at Company Spotlight
May-13-15 06:00AM  IRIDEX to Present at UBS Global Healthcare Conference PR Newswire
May-12-15 01:45PM  IRIDEX CORP Files SEC form 10-Q, Quarterly Report
May-07-15 07:34PM  Iridex posts 1Q profit
05:00PM  IRIDEX Corp Earnings Call scheduled for 5:00 pm ET today
04:37PM  IRIDEX CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
04:05PM  IRIDEX Reports 2015 First Quarter Results PR Newswire
07:07AM  Q1 2015 IRIDEX Corp Earnings Release - After Market Close
Apr-30-15 04:47PM  IRIDEX Announces First Quarter 2015 Conference Call and Release Date at noodls
04:05PM  IRIDEX Announces First Quarter 2015 Conference Call and Release Date PR Newswire
Apr-24-15 08:12PM  10-K for IRIDEX Corp. at Company Spotlight
Apr-16-15 06:30AM  IRIDEX' Total Glaucoma Solution Campaign for US Market to Debut at Annual Congress of the American Society of Cataract and Refractive Surgery PR Newswire +5.02%
Apr-02-15 04:55PM  IRIDEX CORP Files SEC form 10-K, Annual Report
Mar-30-15 06:38AM  IRIDEX Granted U.S. Patent for Disposable Device for Efficient and Predictable Wound Closure in Eye Surgeries at noodls
06:30AM  IRIDEX Granted U.S. Patent for Disposable Device for Efficient and Predictable Wound Closure in Eye Surgeries PR Newswire
Mar-17-15 06:41AM  IRIDEX Announces First Commercial Sales of New Cyclo G6 Glaucoma Laser Systems at noodls
06:30AM  IRIDEX Announces First Commercial Sales of New Cyclo G6 Glaucoma Laser Systems PR Newswire
Mar-09-15 05:13PM  IRIDEX CORP Files SEC form 8-K, Change in Directors or Principal Officers
Mar-05-15 06:31PM  IRIDEX Reports 2014 Fourth Quarter, Year-End Results at noodls -5.75%
06:03PM  Iridex posts 4Q profit
05:00PM  IRIDEX CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
05:00PM  IRIDEX Corp Earnings Call scheduled for 5:00 pm ET today
04:05PM  IRIDEX Reports 2014 Fourth Quarter, Year-End Results PR Newswire
IRIDEX Corporation provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. The company offers laser consoles, such as visible (yellow) photocoagulator consoles, visible (Green) photocoagulator consoles, infrared photocoagulator consoles, micropulse enabled consoles, and multi-wavelength laser system configurations; and ophthalmic delivery devices and other products, including TxCell scanning laser delivery systems, TruFocus laser indirect ophthalmoscopes, slit lamp adapters, and operating microscope adapters. Its ophthalmic delivery devices and other products also comprise MicroPulse P3 Probe, a delivery device used in the cyclophotocoagulation procedure to treat various stages of glaucoma; EndoProbe, a fiber optic delivery device used for endophotocoagulation; G-Probe, a sterile single-use product used in procedures to treat medically and surgically uncontrolled glaucoma; DioPexy Probe, a hand-held instrument used in procedures to treat retinal tears; GreenTip Soft Tip Cannula used to visualize and access the proximity of the retina while performing a fluid air exchange during a vitrectomy procedure; and MoistAir in-line air humidifier that provides humidified air to the eye during fluid air exchange. The company serves research and teaching hospitals, government installations, surgical centers, hospitals, and office clinics. IRIDEX Corporation markets its products through direct and independent sales force in the United States, as well as through independent distributors internationally. The company was formerly known as IRIS Medical Instruments, Inc. and changed its name to IRIDEX Corporation in November 1995. IRIDEX Corporation was founded in 1989 and is headquartered in Mountain View, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Dizon Romeo RPrincipal Accounting OfficerSep 12Option Exercise9.651251,20620,163Sep 14 06:48 PM
Dizon Romeo RPrincipal Accounting OfficerSep 12Sale15.001251,87520,100Sep 14 06:48 PM
NAUMANN-ETIENNE RUEDIGERDirectorSep 07Sale14.767,000103,33364,433Sep 07 07:47 PM
NAUMANN-ETIENNE RUEDIGERDirectorSep 02Sale14.732,51337,01671,433Sep 07 07:47 PM
Dizon Romeo RPrincipal Accounting OfficerAug 23Option Exercise5.928755,18020,975Aug 24 05:50 PM
Dizon Romeo RPrincipal Accounting OfficerAug 23Sale14.5287512,70820,100Aug 24 05:50 PM
Dizon Romeo RPrincipal Accounting OfficerAug 19Option Exercise7.556,20646,84021,975Aug 22 05:02 PM
Dizon Romeo RPrincipal Accounting OfficerAug 19Sale13.526,20683,91720,100Aug 22 05:02 PM
Dizon Romeo RPrincipal Accounting OfficerAug 18Option Exercise5.921,69010,00521,767Aug 22 05:02 PM
Dizon Romeo RPrincipal Accounting OfficerAug 18Sale13.501,69022,81720,100Aug 22 05:02 PM
Dizon Romeo RPrincipal Accounting OfficerAug 16Sale13.7083911,49420,100Aug 17 07:14 PM
Marcellino George RDirectorAug 16Sale13.572,51334,1021,289Aug 17 06:56 PM
Steckel RonaldVP, OperationsJun 06Option Exercise3.866252,41066,250Jun 08 07:05 PM
Steckel RonaldVP, OperationsJun 06Sale13.526258,44865,625Jun 08 07:05 PM
Steckel RonaldVP, OperationsMay 17Option Exercise3.943,33313,13168,958May 18 07:16 PM
Steckel RonaldVP, OperationsMay 17Sale12.814,58358,71865,625May 18 07:16 PM
FITCH SANFORDDirectorApr 22Option Exercise2.275,00011,35046,607Apr 25 06:51 PM
MOORE WILLIAM MChairman and CEOMar 16Option Exercise2.275,00011,350345,931Mar 17 06:57 PM
Steckel RonaldVP, OperationsMar 08Option Exercise3.996,25024,93875,125Mar 09 07:25 PM
Steckel RonaldVP, OperationsMar 08Sale10.4512,000125,40666,875Mar 09 07:25 PM
MOORE WILLIAM MChairman and CEONov 19Buy9.8310,00098,326290,931Nov 19 06:43 PM